FDA Approves Innovative T-Cell Therapy for Blood Cancer Patients

The FDA has approved a new T-cell therapy from Orca Bio that reduces the risk of immune reactions in blood cancer patients undergoing stem cell transplants. The approval marks an important step forward in immunotherapy.